Research desk / NAD+ coenzyme
NAD+ is a coenzyme its precursors NMN and NR reliably raise in human blood — here is the order book of the evidence.
A cited digest of every form and route: which oral precursors move blood NAD+, what the brain and metabolic trials measured, and where the human data stop.
The short read
NAD+ (nicotinamide adenine dinucleotide — a fuel-handling helper molecule every cell uses to turn food into energy) is not a drug and not one product. It is a coenzyme (a helper molecule an enzyme needs to do its job) the body builds itself, and its levels in tissue fall as people age [5]. NAD+ itself is large and barely absorbed when swallowed, so almost everything sold as an oral "NAD+" supplement is really a precursor (a building block the body converts into NAD+ — NMN and NR are the common ones). In randomized human trials, those precursors reliably raised blood NAD+ [3][4]. Whether that translates into a health benefit in people is still unsettled [21].
What the NAD+ order book actually lists
NAD+ is the cell's central redox carrier — it shuttles electrons through glycolysis, the TCA cycle, and oxidative phosphorylation to make ATP — and a consumed substrate for the signaling enzymes sirtuins, PARPs, and CD38 that govern DNA repair, gene regulation, and inflammation [5][12]. Tissue NAD+ declines with age, partly because the NAD-consuming ectoenzyme CD38 rises [2]. That decline is the rationale behind boosting NAD+ with precursors.
The distinction the marketplace blurs is the one this digest keeps exact. Intact oral NAD+ is poorly taken up by cells, so the controlled human evidence runs almost entirely on the precursors. Nicotinamide riboside (NR) raised whole-blood NAD+ by 22%, 51%, and 142% at 100, 300, and 1000 mg/day over eight weeks in healthy overweight adults [4]. Nicotinamide mononucleotide (NMN) at 300-900 mg/day for 60 days raised blood NAD+ at days 30 and 60 across every dose group versus placebo in a multicenter randomized trial [3]. Each form is its own listing with its own measured quote — read them side by side on NMN vs NR precursors, never as one position.
NAD+ as a dietary supplement: what the label actually contains
A bottle labeled "NAD+" almost never contains a meaningful, absorbable dose of NAD+ itself. It contains a precursor — most often NMN, NR, or plain niacin/nicotinamide — because the intact dinucleotide is large, charged, and poorly orally bioavailable [21]. These products are sold as dietary supplements, not approved drugs: NAD+ is not FDA-approved for any disease, and the research summarized here describes what specific studies measured, not a treatment.
The supplement label also carries unsettled regulatory edges. The FDA has taken the position that NMN is excluded from the dietary-supplement definition because it was authorized for investigation as a drug — a contested marketplace dispute, not a finding that NMN is "banned" [21]. Supplement-grade purity and actual content vary widely between products, and third-party testing is not guaranteed. NAD+ and its precursors are not prohibited by WADA.
What the studies actually measured (not 'benefits')
The honest readout reframes "NAD+ benefits" as outcomes that were measured under controlled conditions. The strongest, most reproducible result is pharmacodynamic: oral NMN and NR raise blood NAD+ dose-dependently [3][4]. Functional endpoints are more mixed.
Ten weeks of oral NMN at 250 mg/day improved muscle insulin sensitivity in prediabetic, postmenopausal women, measured by a hyperinsulinemic-euglycemic clamp, with no change in body composition or HbA1c [1]. The multicenter NMN trial at 300-900 mg/day reported improved walking distance and a biological-age measure that did not increase [3]. A 52-week NR trial in nine people with Werner syndrome produced a roughly 140% plasma NAD+ rise alongside improved arterial stiffness and kidney-function measures [13]. None of these is a claim that NAD+ "reverses aging" — a 2025 review concluded human efficacy for hard clinical endpoints remains preliminary [21]. See the full human clinical trials breakdown and the doses used in the research.
Three forms, three routes, one molecule
NAD+ reaches the body through distinct channels, and the evidence is uneven across them. Oral precursors (NMN, NR, nicotinamide) carry the bulk of the controlled human data [3][4]. IV NAD+ infusion evidence is the thinnest in the field: a 5-day, 750 mg/day intravenous pilot improved 6 of 8 cognitive tests versus 2 of 8 on saline [7], but infused NAD+ is cleared from plasma within roughly two hours and large randomized trials are absent. The dealt lens of this digest is neuro-cognition — the Alzheimer's-model, Parkinson's, IV-cognition, and long-COVID evidence is read on NAD+ and the brain. Compounded injectable NAD+ also carries documented quality risk: the FDA issued a Class I recall of a compounded NAD+ injection for elevated bacterial endotoxin. Every claim on this site maps to a numbered citation in the full reference list.
What is NAD supplement used for?
NAD+ is an endogenous coenzyme; oral "NAD+" supplements (usually the precursors NMN or NR) are studied for whether they raise blood NAD+ and affect metabolic, muscle, and cognitive measures [1][3][4]. They are sold as dietary supplements, not approved treatments, and the research here describes measured outcomes rather than recommending any use.
Is NAD just vitamin B3?
Not exactly. NAD+ is a coenzyme the body builds from vitamin-B3-family precursors — niacin, nicotinamide, and nicotinamide riboside (NR). NR and niacin are B3 forms; NAD+ itself is the larger dinucleotide they feed into through the salvage and Preiss-Handler pathways [5][12].
What does NAD do for the body?
NAD+ carries electrons through energy metabolism — glycolysis, the TCA cycle, and oxidative phosphorylation — to make ATP, and serves as a consumed substrate for sirtuins, PARPs, and CD38, the enzymes that govern DNA repair, gene regulation, and inflammation [5]. It sits at the center of both energy production and cellular maintenance signaling.
Is NAD a peptide?
No. NAD+ is a dinucleotide coenzyme — two nucleotides (nicotinamide mononucleotide and adenosine monophosphate) joined by bridging phosphates — not a peptide and not a protein. Its molecular formula is C21H27N7O14P2 and its molecular weight is 663.43 Da [5].
What does NAD stand for?
NAD stands for nicotinamide adenine dinucleotide. The "+" denotes its oxidized form, NAD+, which interconverts with the reduced form NADH as it accepts and donates electrons during metabolism [5].
What does NAD mean in medical terms?
In biochemistry, NAD means nicotinamide adenine dinucleotide, the cell's central redox coenzyme — historically called Coenzyme I, and once abbreviated DPN (diphosphopyridine nucleotide). It is the workhorse electron carrier of metabolism [5].